In some studies, neutrophil-specific MPO and PAD4 ablation or inhibition could improve the disease progression of HF, myocardial infarction, and atrial fibrillation, which all illustrate the fact that NETosis is a pathogenic factor of HF. This evidence concerns the gene MPO and atrial fibrillation.